Major new study finds clues to the genetic causes of osteoarthritis (Update)

July 2, 2012 in Arthritis & Rheumatism

(Medical Xpress) -- UK scientists have discovered more genetic regions associated with the cause of osteoarthritis. Researchers from nine institutions across the UK have described the findings as a significant breakthrough in understanding the genetic risk factors that cause the disease.

Publishing their findings in The Lancet today, the Arthritis Research UK-funded arcOGEN consortium has highlighted eight genetic regions linked to the development of osteoarthritis. Previously, only three osteoarthritis genetic regions had been identified. 

Several of the genetic regions encompass genes that are known to regulate how joints are made and then maintained, making them excellent osteoarthritis candidate genes. Another genetic region contains a gene involved in the regulation of body weight, which is a strong risk factor for osteoarthritis.

The £2.2million project is the world’s biggest ever-genome wide study into osteoarthritis, comparing the genetic differences of 7,400 patients with severe osteoarthritis with 11,000 healthy volunteers. The results were then replicated in over 7,000 OA individuals and 43,000 control individuals, from four European collaborating partners.

Osteoarthritis affects about 40 per cent of people over the age of 70, a total of 8 million people in the UK, causing pain and disability. There is currently no cure for the condition. Treatments for early osteoarthritis are limited to non-surgical options such as pain killers and physiotherapy until joint replacement becomes a viable option. Osteoarthritis is a complex disorder with both environmental and genetic causes. It is estimated that about 50 per cent of an individual’s risk of developing osteoarthritis is due to inherited genetic factors.

Professor Bill Ollier, from the University of Manchester’s Centre for Integrated Medical Research (CIGMR), said: “Osteoarthritis is one the most common conditions affecting adults and is responsible for causing much pain and suffering for a large proportion of the population. Unfortunately, this is becoming a larger health problem as we live longer. We are only now just beginning to identify the genetic and lifestyle factors involved in OA and work out how they interact to allow the disease to develop. Only by doing this will we be able to develop treatments to tackle the disease at an early stage and avoid surgical replacements of joints. This landmark study, supported by the Alzheimer's Research UK, has brought together the major research groups working on OA in collaboration, rather than being in competition. This important study opens up a number of exciting new avenues for tackling this common condition.”

Two of the novel regions are close to genes that immediately suggest clinical implications for osteoarthritis. One, CHST11, affects cartilage proteoglycan (proteins in the cartilage modified with sugar chemicals) and changes in proteoglycan are an active area of development of new treatments for osteoarthritis. A second gene, PTHLH, is the basis for recently developed parathyroid hormone-based treatments for osteoporosis. The research team suggest a next step would be to explore whether these compounds may also be effective in osteoarthritis.

Gillian Wallis, Professor of Genetics in Manchester’s Wellcome Trust Centre for Cell-Matrix Research, said: “It is very exciting that many of the chromosomal regions associated with osteoarthritis contain genes that are involved in the development, production and maintenance of healthy cartilage. This makes sense because cartilage is one of the tissues of the joint that is degraded by the osteoarthritic disease process. Knowing which genes contribute to osteoarthritis susceptibility provides a firm starting point for research into the causes of this complex disease which may identify new targets for drug development.”

Principal investigator of arcOGEN John Loughlin, Professor of Musculoskeletal Research at Newcastle University, said: “We know that osteoarthritis runs in families and that this is due to the genes that people pass on, rather than their shared environment. In this study we were able to say with a high degree of confidence which genetic regions are the major risk factors for developing osteoarthritis: the first time that this has been possible for this common yet complex disease. It’s an important first step.”

Medical director of Arthritis Research UK Professor Alan Silman added: “There is no cure for osteoarthritis yet it affects millions of people around the world. For 60 years we have known that you are twice as likely to have osteoarthritis if your parents have the disease, yet we haven’t known why.

“Until we understand the cause of this complex disease, we cannot hope to find a cure. This is a major breakthrough in our understanding of osteoarthritis which we hope will help us to unlock the genetic basis of the disease.”

Further work is now needed to pinpoint the actual DNA changes within the genetic regions to establish exactly how these changes lead to osteoarthritis.

Professor Loughlin said that they were not yet able to use their discoveries as a tool to predict who was more or less likely to develop the disease, or to predict the degree of osteoarthritis severity, based on the genes they have inherited. Far more genes are involved in causing disease susceptibility than was previously thought, and there are still many left to find.

He added: “However, what we are able to do is to use our genetic discoveries to identify key biological pathways that can now be exploited to develop new treatments.”

Journal reference: The Lancet search and more info website

Provided by University of Manchester

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Ultrasound findings can improve classification of RA

(HealthDay)—Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League ...

Arthritis & Rheumatism created May 15, 2013 | popularity not rated yet | comments 0

Strong genetic component of fibromyalgia suggested

(HealthDay)—A genome-wide linkage scan has identified the chromosome 17p11.2-q11.2 region as the susceptibility locus for fibromyalgia, according to research published in the April issue of Arthritis & ...

Arthritis & Rheumatism created May 11, 2013 | popularity not rated yet | comments 0

Discovery shows fat triggers rheumatoid arthritis

Scientists have discovered that fat cells in the knee secrete a protein linked to arthritis, a finding that paves the way for new gene therapies that could offer relief and mobility to millions worldwide.

Arthritis & Rheumatism created May 08, 2013 | popularity 5 / 5 (5) | comments 0 | with audio podcast

Researchers finds Irish Lupus patients likely to benefit from new treatment

Researchers from the Royal College of Surgeons in Ireland (RCSI) have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus (SLE) could potentially benefit Irish patients who suffer from ...

Arthritis & Rheumatism created May 07, 2013 | popularity not rated yet | comments 0

'Oil for the joints' offers hope for osteoarthritis sufferers

A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers. The new synthetic polymer supplements ...

Arthritis & Rheumatism created May 02, 2013 | popularity 4 / 5 (1) | comments 0


Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...

New research identifies practice changes to improve value and quality of GI procedures

There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).